###begin article-title 0
UCP-2 and UCP-3 Proteins Are Differentially Regulated in Pancreatic Beta-Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: LH. Performed the experiments: KM LH YL LS. Analyzed the data: KM LH YL LS. Contributed reagents/materials/analysis tools: KM LH. Wrote the paper: LH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Increased uncoupling protein-2 (UCP-2) expression has been associated with impaired insulin secretion, whereas UCP-3 protein levels are decreased in the skeleton muscle of type-2 diabetic subjects. In the present studies we hypothesize an opposing effect of glucose on the regulation of UCP-2 and UCP-3 in pancreatic islets.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 332 337 <span type="species:ncbi:9606">Human</span>
Dominant negative UCP-2 and wild type UCP-3 adenoviruses were generated, and insulin release by transduced human islets was measured. UCP-2 and UCP-3 mRNA levels were determined using quantitative PCR. UCP-2 and UCP-3 protein expression was investigated in human islets cultured in the presence of different glucose concentrations. Human pancreatic sections were analyzed for subcellular localization of UCP-3 using immunohistochemistry.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 511 512 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 321 326 <span type="species:ncbi:9606">human</span>
###xml 367 372 <span type="species:ncbi:9606">human</span>
Dominant negative UCP-2 expression in human islets increased insulin secretion compared to control islets (p<0.05). UCP-3 mRNA is expressed in human islets, but the relative abundance of UCP-2 mRNA was 8.1-fold higher (p<0.05). Immunohistochemical analysis confirmed co-localization of UCP-3 protein with mitochondria in human beta-cells. UCP-2 protein expression in human islets was increased approximately2-fold after high glucose exposure, whereas UCP-3 protein expression was decreased by approximately40% (p<0.05). UCP-3 overexpression improved glucose-stimulated insulin secretion.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 141 147 <span type="species:ncbi:9606">humans</span>
###xml 430 436 <span type="species:ncbi:9606">humans</span>
UCP-2 and UCP-3 may have distinct roles in regulating beta-cell function. Increased expression of UCP-2 and decreased expression of UCP-3 in humans with chronic hyperglycemia may contribute to impaired glucose-stimulated insulin secretion. These data imply that mechanisms that suppress UCP-2 or mechanisms that increase UCP-3 expression and/or function are potential therapeutic targets to offset defects of insulin secretion in humans with type-2 diabetes.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Unger1">[1]</xref>
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Poitout1">[2]</xref>
###xml 364 367 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Poitout1">[2]</xref>
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Robertson1">[4]</xref>
###xml 526 529 526 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Unger1">[1]</xref>
###xml 531 534 531 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Poitout1">[2]</xref>
###xml 536 539 536 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-ElAssaad1">[5]</xref>
###xml 956 959 956 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Ashcroft1">[6]</xref>
###xml 961 964 961 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Maechler1">[7]</xref>
###xml 1482 1485 1482 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Langin1">[8]</xref>
Prolonged exposure of islets to high glucose or free fatty acid concentrations causes attenuated glucose-stimulated insulin secretion (GSIS) [1], [2]. A number of explanations have been proposed, including decreased proinsulin biosynthesis, desensitization to the glucose signal, depleted insulin stores, chronic oxidative stress and increased beta-cell apoptosis [2]-[4]. Furthermore, chronic high fatty acid concentrations may be beta-cell toxic in the context of concomitant hyperglycemia, referred to as glucolipotoxicity [1], [2], [5]. Glucose oxidation generates NADH and FADH, which donate electrons to the mitochondrial electron transport chain. Protons subsequently re-enter the mitochondrial matrix via ATP synthase to generate ATP. The increase in ATP results in the closure of the ATP sensitive potassium channels, which in turn leads to depolarization of the cell membrane and an influx of ionized calcium thereby triggering insulin secretion [6], [7]. Therefore, an attenuated increment in mitochondrial membrane proton gradient following glucose oxidation would be expected to attenuate the consequent increment in insulin secretion. One mechanism that may cause a decrease in the mitochondrial membrane proton gradient is leakage of protons down this gradient via uncoupling proteins. To the extent that protons re-enter beta-cell mitochondria via uncoupling proteins and release energy in the form of heat, they will be unavailable for ATP synthase to generate ATP [8].
###end p 11
###begin p 12
###xml 243 246 243 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Argyropoulos1">[9]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Enerback1">[10]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Fleury1">[11]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-VidalPuig1">[12]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-VidalPuig2">[13]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Arsenijevic1">[14]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Schrauwen1">[15]</xref>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Mattson1">[16]</xref>
###xml 224 230 <span type="species:ncbi:9606">humans</span>
Five different uncoupling protein isoforms are known and they have been identified in different tissues. UCP-1 is expressed predominantly in brown adipose tissue, and it is responsible for shivering thermogenesis in newborn humans and rodents [9], [10]. UCP-2 is ubiquitously expressed, whereas UCP-3 is expressed preferentially in skeletal muscle, brown adipose tissue and minimally in heart [11], [12]. Both UCP-2 and UCP-3 prevent the reactive oxygen species formation and therefore protect living cells against oxidative stress [13], [14]. Furthermore, UCP-3 plays a physiological role in fatty acid metabolism by exporting fatty acids from the mitochondria [15]. UCP-4 and UCP-5 are expressed mainly in the nervous system [16].
###end p 12
###begin p 13
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Chan1">[17]</xref>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Krauss1">[21]</xref>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Zhang1">[22]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Briaud1">[24]</xref>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Zhang1">[22]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Joseph1">[25]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-DeSouza1">[26]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Krauss1">[21]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Brown1">[27]</xref>
###xml 1008 1012 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Anello1">[28]</xref>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10116">rats</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 753 758 <span type="species:ncbi:9606">human</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
###xml 934 939 <span type="species:ncbi:9606">human</span>
###xml 1122 1127 <span type="species:ncbi:9606">human</span>
###xml 1273 1278 <span type="species:ncbi:9606">human</span>
###xml 1313 1318 <span type="species:ncbi:9606">human</span>
###xml 1443 1448 <span type="species:ncbi:9606">human</span>
UCP-2 expression is increased by exposure of rodent islets to high levels of glucose and free fatty acids [17]-[21]. Furthermore, UCP-2 expression is upregulated in islets of wild type ob/ob mice and rats fed a high-fat diet [22]-[24]. When ob/ob mice lack a functional UCP-2 gene or when UCP-2 deficient mice were fed with a high-fat diet, GSIS was improved when compared with wild-type mice [22], [25], [26]. Finally, hyperglycemia-induced mitochondrial superoxide activates UCP-2, which subsequently impairs GSIS [21]. These data imply that UCP-2 (and potentially other uncoupling proteins) may be important in the regulation of insulin secretion in health, and may contribute to impaired GSIS in diabetes. To date there is minimal data available in human islets. UCP-2 mRNA transcription is increased by high glucose in human islets [27]. Furthermore, a recent study demonstrated that UCP-2 protein levels are increased by 24% in human islets isolated from diabetic subjects compared to control subjects [28]. The purpose of the present study was to address the following questions: (1) Is UCP-2 protein expression in human islets increased by chronic exposure to high concentrations of glucose, and/or oleic acid? (2) Does endogenous UCP-2 expression regulate GSIS in human islets? (3) Is UCP-3 expressed in human islets, and if so, (4) Does high glucose regulate UCP-3 protein expression? (5) Does UCP-3 over expression regulate GSIS in human islets?
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 15 20 <span type="species:ncbi:9606">human</span>
Procurement of human islets and cell culture
###end title 15
###begin p 16
###xml 371 372 371 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 105 110 <span type="species:ncbi:9606">human</span>
Islets from the pancreas of organ donors were obtained through the Juvenile Diabetes Research Foundation human islet distribution program. Islets were cultured at RPMI medium containing 10% heat-inactivated FCS, 2 mM Glutamax and 100 U/ml Penicillin/Streptomycin (described hereafter as complete medium) supplemented with 5.5 mM glucose in humidified air containing 5% CO2. All tissue culture reagents were from Invitrogen (Carlsbad, CA).
###end p 16
###begin title 17
###xml 14 19 <span type="species:ncbi:9606">human</span>
Generation of human UCP-2 dominant negative adenovirus
###end title 17
###begin p 18
###xml 1146 1150 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Mills1">[29]</xref>
###xml 1391 1396 1373 1378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D212N</sub>
###xml 1437 1441 1419 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Mills1">[29]</xref>
###xml 1530 1534 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-He1">[30]</xref>
###xml 1598 1602 1580 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Lingohr1">[31]</xref>
###xml 1751 1755 1733 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Lingohr2">[32]</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
###xml 1508 1511 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Total RNA was extracted from human islets using a Qiagen RNeasy kit (Qiagen, Santa Clarita, CA), and Omniscript Reverse Transcriptase (Qiagen) was used for each RT reaction. PCR was carried out using Platinium Taq DNA polymerase (Invitrogen) and UCP-2 primers. The PCR primer sequences for human UCP-2 were 5'ATGGTTGGGTTCAAGGCCACAG3' and 5'TCAGAAGGGAGCCTCTCGGGAAG3'. PCR reactions were performed with 2 min initial denaturing step, followed by 35 cycles of 30 sec at 94degreesC, 30 sec at 55degreesC and 1 min at 72degreesC. PCR samples were run on a 1.2% agarose gel, and inserted into pGEM-T Easy vector (Promega, Madison, WI). The sequencing of PCR fragment confirmed 100% homology with published human UCP-2 sequence (GenBank Accession number: A94592). As well as generating a construct with UCP-2 we also generated a dominant negative UCP-2 construct in order to allow us to establish if the endogenous UCP-2 protein is active in regulation of insulin secretion. The rationale here is that as wild type UCP-2 in its functional form is a dimer, the dominant negative approach allows examination of a reduction in functional wild type protein [29]. To generate the dominant negative (dn) mutation, aspartic acid at position 212 was substituted with asparagine using PCR mutagenesis. This mutation was originally characterized by Mills et al., who demonstrated that the expression of UCP-2D212N raises mitochondrial membrane potential [29]. The entire coding region of dnUCP-2 was inserted in the pAdTrack-CMV expression vector [30]. Ad-dnUCP-2 adenovirus was generated using standard procedures [31]. This adenovirus expresses both dnUCP-2 and green fluorescent protein (GFP). Ad-GFP was kindly provided by Dr. C. Rhodes (University of Chigaco, IL)[32].
###end p 18
###begin title 19
###xml 16 22 <span type="species:ncbi:9606">humans</span>
Transduction of humans islets with dnUCP-2 adenovirus
###end title 19
###begin p 20
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 131 136 <span type="species:ncbi:9606">human</span>
One hundred islets were transduced with adenovirus expressing GFP (Ad-GFP) as a control or adenovirus expressing dominant negative human UCP-2 (Ad-dnUCP-2) at 3x106 pfu/islet. Islets were incubated in viral solution at 37degreesC. After 3 hr, islets were washed twice in complete medium, and transferred on a 35-mm suspension culture dish.
###end p 20
###begin title 21
Mitochondrial membrane potential detection
###end title 21
###begin p 22
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Cossarizza1">[33]</xref>
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Reers1">[34]</xref>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Beattie1">[35]</xref>
###xml 603 604 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 754 755 754 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 768 769 768 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 780 781 780 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 783 784 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 797 798 797 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 433 438 <span type="species:ncbi:9606">human</span>
Mitochondrial membrane potential was detected by staining living islets with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1, Molecular Probes, Eugene, OR). JC-1 is a lipophilic dye, which selectively enters into the mitochondria and forms red aggregates as the mitochondria membrane becomes more polarized [33], [34]. Islets were cultured on extracellular matrix-coated chamber slides derived from human bladder carcinoma cells (HTB9, [35]), allowing islets to detach to the slide and spread. Three days later, islets were transduced with Ad-GFP or Ad-dn-UCP-2 at 3x106 pfu/islet as described above. Forty-four hours after transduction, medium was replaced with Krebs Ringer buffer (119 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 1.2 mM KH2PO4, 25 mM NaHCO3, 2 mM glucose). Islets were stained with 10 microg/ml JC-1 for 30 minutes at 37degreesC and examined with a confocal microscope (Leica TCS-SP, Leica Microsystems). Total islet area and mitochondia (red) were measured using Image-Pro Plus 4.1 (Media Cybernetics, Silver Spring, MD).
###end p 22
###begin title 23
###xml 30 35 <span type="species:ncbi:9606">human</span>
Insulin release by transduced human islets
###end title 23
###begin p 24
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Song1">[36]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Ritzel1">[37]</xref>
###xml 470 475 <span type="species:ncbi:9606">human</span>
Fifteen transduced islets were placed in perifusion chambers and perifused for 40 min with oxygenated Kreb's Ringer bicarbonate buffer, pH 7.4, at basal (4 mM) glucose followed by increased (16 mM) glucose concentration for 60 min as previously described in detail [36], [37]. Briefly, perfusate was collected at one-minute intervals and insulin was measured in duplicate every 4 minutes from 24 to 64 minutes with a two-site insulin immunospecific ELISA. Four separate human islet donors were used. One experiment was performed in duplicate (two separate perfusions per islet batch) and three others in triplicate.
###end p 24
###begin title 25
###xml 14 19 <span type="species:ncbi:9606">human</span>
Generation of human UCP-3 adenovirus
###end title 25
###begin p 26
###xml 263 266 263 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 398 401 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 475 480 <span type="species:ncbi:9606">human</span>
The PCR primer sequences for human UCP-3 were 5' ATGGTTGGACTGAAGCCTTCAG3' and 5'TCAAAACGGTGATTCCCGTAAC3'. The sequencing of PCR fragment confirmed 100% homology with published human UCP-3 sequence (GenBank Accession number: U94592). Primers were used to generate EcoRI and XhoI sites, the entire coding region of UCP-3 was inserted into pENTR2B (Invitrogen, Carlsbad, CA) and subsequently into pAd/CMV/DEST adenovirus vector (Invitrogen). Recombinant adenoviruses expressing human UCP-3 and luciferase (control) were generated and purified according to manufacturer's instructions (Invitrogen).
###end p 26
###begin title 27
Western blot analysis
###end title 27
###begin p 28
###xml 579 583 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Hong1">[38]</xref>
###xml 1106 1110 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Pecqueur1">[39]</xref>
###xml 1273 1277 1249 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-MacLellan1">[40]</xref>
###xml 1278 1282 1254 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Gong1">[42]</xref>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 368 374 <span type="species:ncbi:9986">rabbit</span>
###xml 449 455 <span type="species:ncbi:9986">rabbit</span>
###xml 916 921 <span type="species:ncbi:10090">mouse</span>
###xml 1026 1031 <span type="species:ncbi:10090">mouse</span>
###xml 1238 1242 <span type="species:ncbi:10090">mice</span>
###xml 1347 1358 <span type="species:ncbi:3704">horseradish</span>
###xml 1381 1385 <span type="species:ncbi:9925">goat</span>
###xml 1391 1397 <span type="species:ncbi:9986">rabbit</span>
Total protein samples were prepared in Laemmli sample buffer from human islets. Twenty microg of protein was separated on a 12% SDS-PAGE and transferred to PVDF membranes (Bio-Rad, Hercules, CA). Membranes were blocked with 5% nonfat dry milk in 0.1% Tween/Tris-buffered saline (TBS-T), and incubated overnight at 4degreesC in 2.5% milk in TBS-T containing polyclonal rabbit anti-UCP-2 (1:1000; RDI-UCP2MabrX, Research Diagnostics, Flanders, NJ) or rabbit anti-UCP-3 (1:500; AB-3046, Chemicon, Temecula, CA). The specificity of this UCP-2 antibody has been previously documented [38]. To confirm the specificity of UCP-2 antibody, it was incubated with an excess of UCP-2 control peptide (10 microg of peptide per 1 microg of antibody; RDI-UCP2M-CP, Research Diagnostics) for 4 hr before continuing with the membrane overnight at 4degreesC. No UCP-2 signal was detected after this incubation. Furthermore, we used a mouse tissue panel to confirm the antibody specificity. This analysis demonstrated that UCP-2 is expressed in mouse spleen and lung, but not in skeletal muscle, as has been shown previously [39]. We chose to use UCP-3 antibody from Chemicon, because this antibody has been previously extensively validated using knock-out mice and adenoviral overexpression [40]-[42]. Membranes were washed five times with TBS-T and incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG (1:3000; Zymed Laboratories, S. San Francisco, CA) for 1 hr. Proteins were visualized using enhanced chemiluminescence (ECL; Amersham, UK). Filters were stripped using Restore Western Blot Stripping buffer (Pierce, Rockford, IL) and reprobed with anti-beta-actin antibodies (1:1000, Cell Signaling Technology, Beverly, MA). Protein expression levels were analyzed using the Un-Scan-It program (Silk Scientific, Orem, UT).
###end p 28
###begin title 29
Real-time quantitative PCR
###end title 29
###begin p 30
###xml 372 377 <span type="species:ncbi:9606">human</span>
###xml 937 942 <span type="species:ncbi:9606">human</span>
###xml 1011 1016 <span type="species:ncbi:9606">human</span>
Real-time quantitative PCR analysis was performed on LightCycler system (Roche Applied Science, Indianapolis, IN) by SYBR Green I dye detection. The reactions were assembled following the manufacturer's recommendation. Briefly, 20 microl of reaction mixture contain 1x buffer (LC FastStart DNA Master Plus SYBR green, Roche), 1 microM forward and reverse primers, and the human islet cDNA template. The PCR conditions were 10 min at 95degreesC, followed by 45 cycles of 2 s at 95degreesC, 2 s at annealing temperature, and 12 s at 72degreesC. We verified the specificity of PCR by measuring the melting curve of the PCR product at the end of reaction. Fluorescent data are specified for collection during primer extension. The relative cDNA ratio was calculated using alpha-tubulin as a reference calibrator to normalize equal loading of template cDNA: 5'AGAGTCGCGCTGTAAGAAGC3' and 5'TGGTCTTGTCACTTGGCATC3'. The PCR primer sequences for human UCP-2 were 5'TCAATGCCTACAAGACC3' and 5'TCTTGACCACGTCTACA3', and for human UCP-3 5'TGAAGGTCCGATTTCAG3' and 5'GATGTCGTAGGTCACCA3'.
###end p 30
###begin title 31
Immunohistochemistry
###end title 31
###begin p 32
###xml 445 446 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 139 143 <span type="species:ncbi:162683">Mayo</span>
###xml 726 732 <span type="species:ncbi:9913">bovine</span>
###xml 837 843 <span type="species:ncbi:9986">rabbit</span>
###xml 872 877 <span type="species:ncbi:10090">mouse</span>
###xml 938 948 <span type="species:ncbi:10141">guinea pig</span>
###xml 993 997 <span type="species:ncbi:9925">Goat</span>
Human pancreatic specimens of non-diabetic subjects were obtained from normal pancreas removed at surgery for pancreatic adenomas from the Mayo Clinic (Rochester, MN). A pancreatic specimen that morphologically appeared to be unaffected by the underlying disease was fixed in formaldehyde and embedded in paraffin for subsequent staining. Four microM sections were were deparaffinized in toluene, rehydrated in grades of alcohol, and washed in H2O. All slides were subject to antigen-retrieval protocols using antigen unmasking buffer (Vector Laboratories, Burlingame, CA). After antigen unmasking, the slides were cooled to room temperature, permeabilized in 0.4% Triton X-100/TBS, and blocked with 0.2% Tween 20/3% IgG-free bovine serum albumin (BSA)/TBS. Primary Ab's were diluted in the blocking solution at the following dilutions: rabbit anti-UCP3, 1:75 (Chemicon), mouse anti-mitochondria, 1:200 (ab3298, abcam, Cambridge, MA) and guinea pig anti-insulin 1:500 (Dako, Carpinteria, CA). Goat-derived secondary Ab's conjugated to FITC or Cy3 were diluted 1:200 (Jackson ImmunoResearch Laboratories, West Grove, PA). To determine the specificity of UCP-3 antibody, it was incubated with 10-fold excess of UCP-3 control peptide (AG769, Chemicon) for 1 hr before continuing with immunostaining. All slides were mounted with Vectashield (Vector Laboratories). Fluorescent slides were viewed using a Leica DXMRA confocal microscope and images acquired using Volocity software (Improvision, Lexington, MA).
###end p 32
###begin title 33
Glucose-stimulated insulin secretion (GSIS)
###end title 33
###begin p 34
###xml 400 405 <span type="species:ncbi:9606">human</span>
For acute insulin release in response to glucose, islets were washed and preincubated (30 min) in KRB containing 2.8 mM glucose. The KRB was then replaced by KRB containing 2.8 mM glucose for 1 h (basal), followed by additional 1 h incubation in KRB containing 16.7 mM glucose. Islets were extracted with 0.18 N HCI in 70% ethanol for determination of insulin content. Insulin was determined using a human insulin ELISA kit (Alpco, Windham, NH).
###end p 34
###begin title 35
Statistics
###end title 35
###begin p 36
###xml 139 140 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Results are presented as means+/-SE. Statistical calculations were carried out by student's t-test using GraphPad Prism (San Diego, CA). A p-value <0.05 was taken to indicated a significant difference.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
###xml 65 70 <span type="species:ncbi:9606">human</span>
Glucose and fatty acid regulation of UCP-2 protein expression in human islets
###end title 38
###begin p 39
###xml 50 51 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 162 169 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g001">Fig. 1A</xref>
###xml 257 258 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 524 533 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g001">figure 1B</xref>
###xml 632 633 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 822 823 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 643 648 <span type="species:ncbi:9606">human</span>
###xml 782 787 <span type="species:ncbi:9606">human</span>
UCP-2 protein expression was increased 2.6+/-0.6 (p<0.05) fold in islets cultured for 24 hr at 11 mM glucose, when compared to islets cultured at 5.5 mM glucose (Fig. 1A). Insulin release from human islets increased 4+/-1-fold in response to 11 mM glucose (p<0.05, data not shown). In order to evaluate the effect of free fatty acids on UCP-2 protein expression in the presence of high glucose, isolated human islets were cultured for 24 hr in 11 mM glucose containing medium with or without 0.45 mM oleic acid. As shown in figure 1B, oleic acid potentiated the effect of high glucose by increasing UCP-2 expression 1.5+/-0.1-fold (p<0.05) in human islets in the presence of 11 mM glucose when compared to islets cultured with 11 mM glucose without oleic acid. Insulin release from human islets increased (1.6+/-0.2-fold, p<0.05) in response to oleic acid (data not shown). We also examined the effect of 0.45 mM oleic acid on UCP-2 expression at 4 mM glucose. Under these conditions, oleic acid increased UCP-2 expression by 1.3+/-0.1-fold (data not shown).
###end p 39
###begin title 40
###xml 58 63 <span type="species:ncbi:9606">human</span>
UCP-2 protein is upregulated by glucose and oleic acid in human islets.
###end title 40
###begin p 41
###xml 280 292 280 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Upper panel,</italic>
###xml 370 381 370 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 542 543 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 553 554 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2 7 <span type="species:ncbi:9606">Human</span>
###xml 66 71 <span type="species:ncbi:9606">Human</span>
###xml 522 527 <span type="species:ncbi:9606">human</span>
A Human islets were cultured at 5.5 or 11 mM glucose for 24 hr. B Human islets were cultured at 11 mM glucose plus 1% BSA containing medium (control) or supplemented with 0.45 mM oleic acid for 24 hr. Total protein extracts were analyzed on a Western blot using UCP-2 antibodies. Upper panel, The intensities of the protein signal were quantified by scanning of images; lower panel, the UCP-2 and beta-actin in one representative experiment. All values are mean+/-SE of at least four independent experiments from separate human islet donors (t-test; *, p<0.05 relative to control).
###end p 41
###begin title 42
###xml 72 77 <span type="species:ncbi:9606">human</span>
Effect of dominant negative UCP-2 misexpression on insulin secretion by human islets
###end title 42
###begin p 43
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g002">Fig. 2A</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Cossarizza1">[33]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Reers1">[34]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Feeney1">[43]</xref>
###xml 688 695 688 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g002">Fig. 2B</xref>
###xml 844 851 844 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g002">Fig. 2C</xref>
###xml 978 979 976 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1095 1096 1091 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 768 773 <span type="species:ncbi:9606">human</span>
Adenoviral misexpression of dnUCP-2 resulted in an approximate 4-fold increase in UCP-2 protein expression compared to control human islets (Fig. 2A). Furthermore, adenoviral-mediated increase in UCP-2 protein expression indicates that this band is indeed UCP-2. To evaluate whether dnUCP-2 expression alters mitochondrial membrane potential, dnUCP-2 and GFP expressing human islets were stained with a mitochondria-specific voltage-sensitive JC-1 dye. The intensity of JC-1 red fluorescence is increased as mitochondrial membrane potential is increased [33], [34], [43]. The islets that expressed dnUCP-2 had a significant increase in membrane potential when compared to control islets (Fig. 2B). To determine the potential for UCP-2 to regulate insulin secretion in human islets, they were transduced with Ad-dnUCP-2 or Ad-GFP and perifused (Fig. 2C). The relative increase in insulin secretion in dnUCP-2 expressing islets compared to GFP expressing islets was 85.6+/-12.7% (p<0.001) at basal glucose (4 mM), whereas during glucose stimulation (16 mM), the relative increase was 44.2+/-8.5% (p<0.001) in islets expressing dnUCP-2 vs. GFP.
###end p 43
###begin title 44
###xml 54 59 <span type="species:ncbi:9606">human</span>
Dominant negative UCP-2 enhances insulin secretion in human islets.
###end title 44
###begin p 45
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 930 931 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 941 942 908 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 159 164 <span type="species:ncbi:9606">Human</span>
###xml 528 533 <span type="species:ncbi:9606">Human</span>
###xml 861 866 <span type="species:ncbi:9606">human</span>
A Levels of UCP-2 protein in human islets following adenoviral misexpression of dn-UCP-2 (+) or GFP (-). B DnUCP-2 increases mitochondrial membrane potential. Human islets grown on extracellular-matrix-coated slides were transduced with Ad-dnUCP-2 or Ad-GFP. Mitochondrial membrane potential was detected by live staining with JC-1, and the JC-1 and islet cell area were measured using Image-Pro Plus software. Bar graph shows the percentage of JC-1 (area) divided by total islet area (t-test; *, p<0.05 relative to control). C Human islets were transduced with Ad-dnUCP-2 (blacksquare, square, filled) or Ad-GFP (square, control) and cultured in suspension at 5.5 mM glucose before perifusion. Islets were perifused at 4 mM and 16 mM glucose and insulin concentrations were measured every 4 min. Results are of four independent experiments using four separate human islet donors. Data are presented as means+/-SE and analyzed by t-test, *, p<0.001.
###end p 45
###begin title 46
###xml 20 25 <span type="species:ncbi:9606">human</span>
UCP-3 expression in human islets
###end title 46
###begin p 47
###xml 83 90 83 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g003">Fig. 3A</xref>
###xml 493 494 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 801 802 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 809 816 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g003">Fig. 3B</xref>
###xml 1210 1217 1206 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g003">Fig. 3C</xref>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 307 312 <span type="species:ncbi:9606">human</span>
###xml 414 419 <span type="species:ncbi:9606">human</span>
###xml 428 433 <span type="species:ncbi:9606">Human</span>
###xml 593 598 <span type="species:ncbi:9606">human</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 871 876 <span type="species:ncbi:9606">human</span>
###xml 1146 1151 <span type="species:ncbi:9606">human</span>
A single mRNA band of the expected size for UCP-3 was amplified from human islets (Fig. 3A). The cloning and sequencing of the PCR fragment confirmed perfect homology with the published long form of human UCP-3 mRNA sequence (GenBank Accession number: NM003356). Having identified transcription of UCP-3 in human islets, we used quantitative PCR in order to measure the relative abundance of UCP2 and UCP3 mRNA in human islets. Human islets had 8.1+/-1.4-fold more UCP2 compared to UCP3 mRNA (p<0.05, n = 25, different glucose concentrations). We next investigated UCP-3 protein expression in human islets using western blotting and immunohistochemistry. UCP-3 protein expression was decreased by 40+/-14% in human islets cultured at 11 mM glucose, when compared to islets cultured at 5.5 mM glucose (p<0.05, Fig. 3B). To examine the expression of UCP-3 in the pancreas, human pancreatic sections were immunostained with an antibody against the C-terminus of UCP-3. To test antibody specificity, we blocked the UCP-3 antibody signal with specific UCP-3 peptide before staining. No positive staining was observed (data not shown). Next we stained human pancreatic tissue with UCP-3 and mitochondria antibodies (Fig. 3C). The beta-cells had a punctuate staining of UCP-3 that colocalized with mitochondria in beta-cells.
###end p 47
###begin title 48
###xml 22 27 <span type="species:ncbi:9606">human</span>
UCP-3 is expressed in human islets.
###end title 48
###begin p 49
###xml 404 405 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2 7 <span type="species:ncbi:9606">Human</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 74 79 <span type="species:ncbi:9606">Human</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
A Human UCP-2, UCP-3 and alpha-tubulin mRNA expression in human islets. B Human islets were cultured at 5.5 or 11 mM glucose, and total protein extracts were analyzed on a western blot using UCP-3 antibodies. The intensities of the protein signal were quantified by scanning of images; blots for UCP-3 and beta-actin is shown for one representative experiment. Data are expressed as means+/-SE, n = 3, * p<0.05. C UCP-3 is expressed in human pancreatic islets, where it colocalizes with mitochondria. A representative layer of human pancreata is depicted showing UCP-3, mitochondria and overlay. Images were acquired using confocal microscope and imaged at x63 magnification, bar = 20 microm.
###end p 49
###begin p 50
###xml 231 238 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g004">Fig. 4A</xref>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 783 790 783 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g004">Fig. 4B</xref>
###xml 948 955 948 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001397-g004">Fig. 4C</xref>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
###xml 926 931 <span type="species:ncbi:9606">human</span>
To investigate the effect of UCP-3 overexpression on GSIS, we prepared UCP-3 adenoviruses. Adenoviral overexpression of UCP-3 resulted in an approximate 3-fold increase in UCP-3 protein expression compared to control human islets (Fig. 4A). Forty-eight hr after transduction, we performed GSIS assays in human islets. No significant changes in insulin secretion were observed at basal levels at 2.8 mM glucose in UCP-3 expressing islets compared to control islets. However, as already seen in the perifusion experiment, dnUCP-2 increased basal insulin secretion by 1.5-fold compared to untreated control islets (p<0.05). Stimulated insulin secretion at 16.7 mM glucose was significantly increased in human islets expressing UCP-3 or dnUCP-2 (1.8- and 2.1-fold, respectively, p<0.05, Fig. 4B) compared to scrambled control. This resulted in a 37% and 40% increase in the stimulatory index by UCP-3 and dnUCP-2, respectively in human islets (p<0.05, Fig. 4C).
###end p 50
###begin title 51
###xml 24 29 <span type="species:ncbi:9606">human</span>
UCP3 over expression in human islets increases glucose-stimulated insulin secretion.
###end title 51
###begin p 52
###xml 77 82 <span type="species:ncbi:9606">human</span>
A Western blot analysis of UCP-3 expression in transduced islets. B Isolated human pancreatic islets were cultured on extracellular matrix-coated dishes and transduced with adenoviruses expressing control virus (luciferase, Luc), UCP-3 or dnUCP-2. Basal and stimulated insulin secretion indicate the amount secreted during 1-hour incubations at 2.8 (basal) and 16.7 mM (stimulated) glucose following the 2-day culture period after transduction, normalized to whole islet insulin content. C Stimulatory index denotes the amount of stimulated divided by the amount of basal insulin secretion. Data represent results of two different experiments from two different organ donors in quadruplicate. Results are means+/-SE, *p<0.05 compared to control.
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Chan1">[17]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Zhang1">[22]</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Anello1">[28]</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Li1">[44]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Anello1">[28]</xref>
###xml 145 150 <span type="species:ncbi:9606">human</span>
UCP-2 expression is increased in rodent islets in response to either chronic high glucose or free fatty acid concentration exposure and diabetic human islets [17]-[22], [28], [44]. This increased UCP-2 expression may contribute to impaired GSIS in type-2 diabetes [28]. Uncoupling proteins therefore have become an interesting focus for hyperglycemia mediated impaired insulin secretion.
###end p 54
###begin p 55
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Brown1">[27]</xref>
###xml 417 421 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Chan3">[45]</xref>
###xml 810 814 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Lameloise1">[18]</xref>
###xml 816 820 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Patane1">[20]</xref>
###xml 822 826 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Li1">[44]</xref>
###xml 828 832 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Medvedev1">[46]</xref>
###xml 964 968 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Lupi1">[47]</xref>
###xml 1005 1009 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Maedler1">[48]</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 289 295 <span type="species:ncbi:9606">humans</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 787 792 <span type="species:ncbi:10090">mouse</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
Brown et al. reported that UCP-2 mRNA levels were increased three-fold in human islets cultured at 22 mM glucose for 24 hr [27]. We observed a similar increase in UCP-2 protein when cells were cultured at the presence of 11 mM glucose for 24 hr, glucose concentration typically present in humans with diabetes. In line with these data and the concept of glucotoxicity, UCP-2 overexpression impairs beta-cell function [45]. This increased UCP-2 expression in the presence of glucose was further amplified by 50% by addition of the actively oxidized fatty acid oleic acid to human islets at a concentration typically present in diabetes (approximately0.45 mM). These data are in agreement with the increase of UCP-2 expression by free fatty acids in isolated rodent islets and in cultured mouse insulinoma cells [18], [20], [44], [46]. This may also be a possible underlying mechanism of free fatty acid induced impaired GSIS in human islets shown during perifusion [47] as well as during static incubation [48]. Taken together these data suggest that the chronically increased glucose and fatty acid concentrations typically present in type-2 diabetes would have an additive effect to increase the expression of UCP-2 protein in islets, an effect that would be expected to attenuate GSIS. The fact that both glucose and oleic acid had this effect implies that the upregulation of UCP-2 protein expression is signaled by traffic through the tricarboxylic acid cycle or a down stream effect of this.
###end p 55
###begin p 56
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Zhang1">[22]</xref>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
###xml 622 627 <span type="species:ncbi:9606">human</span>
###xml 776 781 <span type="species:ncbi:9606">human</span>
Having established that UCP-2 is upregulated under conditions present in type-2 diabetes (high glucose concentrations and free fatty acid concentrations) we sought to establish if the endogenous UCP-2 protein expressed in human islets plays a role in insulin secretion. Rodent studies demonstrated that islets isolated from UCP-2 knock-out mice, when compared to wild-type islets, secrete more insulin when cultured in basal and high glucose concentrations [22]. Therefore to establish if the endogenous UCP-2 protein expressed in human islets regulated insulin secretion we employed a dominant negative UCP-2 approach in human islets. Using this approach we report increased insulin secretion in response to basal as well as high glucose concentrations in isolated perifused human islets expressing a dominant negative form of UCP-2.
###end p 56
###begin p 57
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Chan2">[23]</xref>
###xml 968 972 968 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Schrauwen2">[49]</xref>
###xml 974 978 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Schrauwen3">[50]</xref>
###xml 1099 1103 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Schrauwen2">[49]</xref>
###xml 1236 1240 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Schrauwen2">[49]</xref>
###xml 1242 1246 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Clapham1">[51]</xref>
###xml 1248 1252 1248 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Son1">[52]</xref>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
###xml 578 583 <span type="species:ncbi:9606">human</span>
###xml 1115 1119 <span type="species:ncbi:10090">mice</span>
We also report that UCP-3 is expressed in human islets. Previously, when the PCR method was used to amplify UCP RNAs in human islets, only UCP-2 RNA was detected [23]. This first report of UCP-3 expression in human islets poses additional questions about the potential role of UCPs in the modulation of insulin secretion in response to glucose. We investigated the relationship between UCP-2 and UCP-3 mRNA in human islets and report that the level of UCP-3 mRNA expression in human islets was only around 10% of that of UCP-2. We also report that UCP-3 protein is expressed in human pancreatic islets. Chronic exposure of islets to high glucose concentrations attenuated UCP-3 protein expression, whereas UCP-2 protein levels were increased. This suggests a different role of UCP-3 on glucose homeostasis. UCP-3 protein levels were lower in skeletal muscle of prediabetic (impaired glucose tolerance) and type-2 diabetic subjects compared to healthy control subjects [49], [50]. Furthermore, it was reported that UCP-3 protein level was negatively correlated with plasma glucose and insulin levels [49]. Moreover, mice overexpressing UCP-3 have reduced fasting plasma glucose and insulin levels indicating improved glucose homeostasis [49], [51], [52].
###end p 57
###begin p 58
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-MacLellan1">[40]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Schrauwen1">[15]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-MacLellan1">[40]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Echtay1">[53]</xref>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001397-Hesselink1">[54]</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 320 325 <span type="species:ncbi:9606">human</span>
Because UCP-3 protein levels were decreased at high glucose concentrations, we over-expressed UCP-3 in isolated human islets and measured insulin secretion at basal and increased glucose concentrations. Interestingly, both UCP-3 overexpression and UCP-2 depletion resulted in a 1.4-fold increased GSIS index in isolated human islets. Recent studies demonstrated that modest overexpression of UCP-3 in muscle cells suppressed reactive oxygen species (ROS) production and increased fatty acid oxidation [40]. These results suggest that increased expression of UCP-3 may be beneficial by preventing harmful ROS production and protecting mitochondria against fat accumulation by improving fatty acid metabolism [15], [40], [53]. Therefore, low UCP-3 levels may contribute to the pathogenesis of type-2 diabetes [54].
###end p 58
###begin p 59
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 271 276 <span type="species:ncbi:9606">human</span>
###xml 366 371 <span type="species:ncbi:9606">human</span>
###xml 503 508 <span type="species:ncbi:9606">human</span>
###xml 628 633 <span type="species:ncbi:9606">human</span>
###xml 677 685 <span type="species:ncbi:9606">patients</span>
###xml 903 909 <span type="species:ncbi:9606">humans</span>
###xml 1275 1281 <span type="species:ncbi:9606">humans</span>
In summary, we report here that UCP-2 protein expression is increased in response to glucose in human islets, confirming the corresponding findings made in rodent islets. Moreover, by use of a dominant negative approach we demonstrate that endogenous UCP-2 expression in human islets negatively regulates insulin secretion. We report that UCP-3 is also expressed in human islets, and its expression is decreased in response to high glucose concentrations. Finally, we demonstrate that GSIS is increased human islets over expressing UCP-3. These studies support the emerging concept that UCP-2 (and possibly UCP-3) expression in human islets may contribute to decreased GSIS in patients with type-2 diabetes who are exposed to chronically increased glucose levels. Moreover, these data imply that UCP-2 and UCP-3 may have distinct roles in regulating beta-cell function. Increased expression of UCP-2 in humans with chronic hyperglycemia and/or increased fatty acid concentrations may contribute to impaired GSIS. On the other hand, decreased expression of UCP-3 in high glucose concentrations may impair beta-cell function, implicating that mechanisms that increase UCP-3 expression and/or function are potential therapeutic targets to offset defects of insulin secretion in humans with type-2 diabetes.
###end p 59
###begin p 60
###xml 42 47 <span type="species:ncbi:9606">Human</span>
We thank Dr. P.C. Butler for his support. Human islets were provided through the Islet Cell Resource Consortium, administered by the ABCC and supported by NCRR, NIDDK and JDRF. We thank Dr C. Rhodes for Ad-GFP adenovirus.
###end p 60
###begin title 61
References
###end title 61
###begin article-title 62
Lipotoxicity in the pathogenesis of obesity-dependent niddm. Genetic and clinical implications.
###end article-title 62
###begin article-title 63
Minireview: Secondary beta-cell failure in type 2 diabetes-a convergence of glucotoxicity and lipotoxicity.
###end article-title 63
###begin article-title 64
###xml 22 27 <span type="species:ncbi:9606">human</span>
Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function.
###end article-title 64
###begin article-title 65
Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection.
###end article-title 65
###begin article-title 66
Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death.
###end article-title 66
###begin article-title 67
Atp-sensitive k+ channels and insulin secretion: Their role in health and disease.
###end article-title 67
###begin article-title 68
Mitochondrial function in normal and diabetic beta-cells.
###end article-title 68
###begin article-title 69
Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion.
###end article-title 69
###begin article-title 70
Uncoupling proteins and thermoregulation.
###end article-title 70
###begin article-title 71
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese.
###end article-title 71
###begin article-title 72
Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia.
###end article-title 72
###begin article-title 73
Ucp3: An uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue.
###end article-title 73
###begin article-title 74
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Energy metabolism in uncoupling protein 3 gene knockout mice.
###end article-title 74
###begin article-title 75
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production.
###end article-title 75
###begin article-title 76
Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes.
###end article-title 76
###begin article-title 77
Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death.
###end article-title 77
###begin article-title 78
###xml 90 93 <span type="species:ncbi:10116">rat</span>
Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets.
###end article-title 78
###begin article-title 79
Uncoupling protein 2: A possible link between fatty acid excess and impaired glucose-induced insulin secretion?
###end article-title 79
###begin article-title 80
Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia.
###end article-title 80
###begin article-title 81
Role of atp production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition.
###end article-title 81
###begin article-title 82
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction.
###end article-title 82
###begin article-title 83
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.
###end article-title 83
###begin article-title 84
Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: Mechanism of action.
###end article-title 84
###begin article-title 85
###xml 124 128 <span type="species:ncbi:10116">rats</span>
Differential effects of hyperlipidemia on insulin secretion in islets of langerhans from hyperglycemic versus normoglycemic rats.
###end article-title 85
###begin article-title 86
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet.
###end article-title 86
###begin article-title 87
Inhibition of ucp2 expression reverses diet-induced diabetes mellitus by effects on both insulin secretion and action.
###end article-title 87
###begin article-title 88
###xml 80 85 <span type="species:ncbi:9606">human</span>
Glucose induces and leptin decreases expression of uncoupling protein-2 mrna in human islets.
###end article-title 88
###begin article-title 89
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.
###end article-title 89
###begin article-title 90
Regulation of cellular oncosis by uncoupling protein 2.
###end article-title 90
###begin article-title 91
A simplified system for generating recombinant adenoviruses.
###end article-title 91
###begin article-title 92
Irs-3 inhibits irs-2-mediated signaling in pancreatic beta-cells.
###end article-title 92
###begin article-title 93
Activation of irs-2-mediated signal transduction by igf-1, but not tgf-alpha or egf, augments pancreatic beta-cell proliferation.
###end article-title 93
###begin article-title 94
A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the j-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (jc-1).
###end article-title 94
###begin article-title 95
J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential.
###end article-title 95
###begin article-title 96
###xml 21 26 <span type="species:ncbi:9606">human</span>
Ex vivo expansion of human pancreatic endocrine cells.
###end article-title 96
###begin article-title 97
###xml 31 36 <span type="species:ncbi:9606">human</span>
Pulsatile insulin secretion by human pancreatic islets.
###end article-title 97
###begin article-title 98
###xml 52 57 <span type="species:ncbi:9606">human</span>
Glucose stimulates pulsatile insulin secretion from human pancreatic islets by increasing secretory burst mass: Dose-response relationships.
###end article-title 98
###begin article-title 99
Effects of adenoviral overexpression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells.
###end article-title 99
###begin article-title 100
Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation.
###end article-title 100
###begin article-title 101
Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells.
###end article-title 101
###begin article-title 102
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Expression of uncoupling protein-3 in subsarcolemmal and intermyofibrillar mitochondria of various mouse muscle types and its modulation by fasting.
###end article-title 102
###begin article-title 103
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3.
###end article-title 103
###begin article-title 104
A cuvette-based fluorometric analysis of mitochondrial membrane potential measured in cultured astrocyte monolayers.
###end article-title 104
###begin article-title 105
Induction of uncoupling protein 2 mrna in beta-cells is stimulated by oxidation of fatty acids but not by nutrient oversupply.
###end article-title 105
###begin article-title 106
Uncoupling protein 2 and islet function.
###end article-title 106
###begin article-title 107
Regulation of the uncoupling protein-2 gene in ins-1 beta-cells by oleic acid.
###end article-title 107
###begin article-title 108
###xml 83 88 <span type="species:ncbi:9606">human</span>
Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and bcl-2 regulated.
###end article-title 108
###begin article-title 109
###xml 93 98 <span type="species:ncbi:9606">human</span>
Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function.
###end article-title 109
###begin article-title 110
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes.
###end article-title 110
###begin article-title 111
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: Restoration by rosiglitazone treatment.
###end article-title 111
###begin article-title 112
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 20 25 <span type="species:ncbi:9606">human</span>
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean.
###end article-title 112
###begin article-title 113
###xml 37 52 <span type="species:ncbi:10090">transgenic mice</span>
Reduction of diet-induced obesity in transgenic mice overexpressing uncoupling protein 3 in skeletal muscle.
###end article-title 113
###begin article-title 114
Superoxide activates mitochondrial uncoupling proteins.
###end article-title 114
###begin article-title 115
Towards comprehension of the physiological role of ucp3.
###end article-title 115
###begin p 116
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 116
###begin p 117
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Larry L. Hillblom Foundation 2003/1Mc (LH), 2005/1C (KM) and American Diabetes Association 706JF41 (KM)
###end p 117

